Lassa immune serum.
作者信息
Clayton A J
出版信息
Bull World Health Organ. 1977;55(4):435-9.
Abstract
摘要
相似文献
1
Lassa immune serum.拉沙热免疫血清。
Bull World Health Organ. 1977;55(4):435-9.
2
[Further comment on Lassa fever].[关于拉沙热的进一步评论]
Pieleg Polozna. 1981(9):5-6.
3
[Development and study of immunoglobulins against Lassa fever].
Vopr Virusol. 1997 Mar-Apr;42(2):71-4.
4
Antibody therapy for Lassa fever.拉沙热的抗体治疗。
Curr Opin Virol. 2019 Aug;37:97-104. doi: 10.1016/j.coviro.2019.07.003. Epub 2019 Aug 8.
5
A serological survey of Lassa fever in Liberia.利比里亚拉沙热血清学调查。
Bull World Health Organ. 1978;56(5):811-3.
6
Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization.利比里亚的地方性拉沙热。IV. 选择用于被动免疫治疗的最佳有效血浆。
Trans R Soc Trop Med Hyg. 1985;79(3):380-4. doi: 10.1016/0035-9203(85)90388-8.
7
Strain-specific antibody response to Lassa virus in the local population of west Africa.西非当地人群对拉沙病毒的毒株特异性抗体反应。
J Clin Virol. 2008 May;42(1):40-4. doi: 10.1016/j.jcv.2007.11.019. Epub 2007 Dec 31.
8
Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys.免疫血浆联合利巴韦林对食蟹猴拉沙热的强化治疗
J Infect Dis. 1984 Mar;149(3):420-7. doi: 10.1093/infdis/149.3.420.
9
[A patient with Lassa fever from the Upper Volta, diagnosed in the Netherlands].
Ned Tijdschr Geneeskd. 1982 Mar 27;126(13):566-9.
10
Management of Lassa fever.拉沙热的管理
Lancet. 1984 Sep 29;2(8405):728-9.
引用本文的文献
1
Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice.佐剂对小鼠体内拉沙病毒糖蛋白亚基的免疫原性有不同调节作用。
Front Trop Dis. 2022;3. doi: 10.3389/fitd.2022.847598. Epub 2022 Mar 10.
2
Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design.拉沙热的临床特征：系统综述临床报告和研究，为临床试验设计提供信息。
PLoS Negl Trop Dis. 2021 Sep 21;15(9):e0009788. doi: 10.1371/journal.pntd.0009788. eCollection 2021 Sep.
3
Lassa Virus Treatment Options.拉沙病毒的治疗选择。
Microorganisms. 2021 Apr 7;9(4):772. doi: 10.3390/microorganisms9040772.
4
A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot.一种快速研究需求评估方法，用于确定证据差距，为应对疫情提供信息，确定临床研究重点——拉沙热试点研究结果。
BMC Med. 2019 Jun 11;17(1):107. doi: 10.1186/s12916-019-1338-1.
5
Native functionality and therapeutic targeting of arenaviral glycoproteins.沙粒病毒糖蛋白的天然功能与治疗靶点
Curr Opin Virol. 2016 Jun;18:70-5. doi: 10.1016/j.coviro.2016.04.001. Epub 2016 Apr 19.
6
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.沙粒病毒聚糖护盾促进中和抗体逃逸及持续性感染。
PLoS Pathog. 2015 Nov 20;11(11):e1005276. doi: 10.1371/journal.ppat.1005276. eCollection 2015 Nov.
7
Therapeutic antibodies: current state and future trends--is a paradigm change coming soon?治疗性抗体：现状与未来趋势——范式转变即将到来？
Methods Mol Biol. 2009;525:1-27, xiii. doi: 10.1007/978-1-59745-554-1_1.
8
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.针对严重急性呼吸综合征冠状病毒、尼帕病毒和亨德拉病毒的强效人源单克隆抗体。
Expert Opin Biol Ther. 2009 Mar;9(3):355-68. doi: 10.1517/14712590902763755.
9
The regulation and maturation of antiviral immune responses.抗病毒免疫反应的调节与成熟
Adv Virus Res. 2004;63:181-238. doi: 10.1016/S0065-3527(04)63003-X.
10
Passive antibody administration (immediate immunity) as a specific defense against biological weapons.被动抗体给药（即时免疫）作为针对生物武器的一种特异性防御手段。
Emerg Infect Dis. 2002 Aug;8(8):833-41. doi: 10.3201/eid0808.010516.
本文引用的文献
1
Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus.拉沙热，一种源自西非的人类新型病毒疾病。3. 病毒的分离与特性鉴定。
Am J Trop Med Hyg. 1970 Jul;19(4):680-91. doi: 10.4269/ajtmh.1970.19.680.
2
Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972.1972年3月至4月，利比里亚佐尔佐尔医院疫情期间拉沙热病例的临床表现。
Am J Trop Med Hyg. 1973 Nov;22(6):780-4. doi: 10.4269/ajtmh.1973.22.780.
3
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases.1970 - 1972年塞拉利昂东部省的拉沙热。II. 对部分医院病例的临床观察和病毒学研究。
Am J Trop Med Hyg. 1974 Nov;23(6):1140-9. doi: 10.4269/ajtmh.1974.23.1140.
4
Diagnosis of Lassa fever and the isolation and management of patients.拉沙热的诊断以及患者的隔离与管理。
Bull World Health Organ. 1975;52(4-6):707-15.
5
Lassa fever in Panguma Hospital, Sierra Leone, 1973-6.1973年至1976年，塞拉利昂庞古马医院的拉沙热疫情。
Br Med J. 1977 May 28;1(6073):1399-402. doi: 10.1136/bmj.1.6073.1399.
6
Indirect immunofluorescence for the diagnosis of Lassa fever infection.用于诊断拉沙热感染的间接免疫荧光法。
Bull World Health Organ. 1975;52(4-6):429-36.
7
Antigenic properties of the arenaviruses.沙粒病毒的抗原特性。
Bull World Health Organ. 1975;52(4-6):421-7.
Zotero 插件